Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
References SURMOUNT-5 head-to-head trial (NEJM, May 2025) summary via American College of Cardiology: SURPASS-2 primary publication (NEJM, 2021): Eli Lilly SURMOUNT-1 results announcement (NEJM data): Insights into the Mechanism of Action of Tirzepatide (PMC narrative review): Tirzepatide is an imbalanced and biased dual GIP/GLP-1 receptor agonist (PMC): SURMOUNT-5 GI tolerability / discontinuation data (Applied Clinical Trials, tctmd, DiabetesontheNet coverage): SURMOUNT-1 to -4 GI tolerability (Rubino 2025, Diabetes Obesity & Metabolism): Community sentiment context Reddit GLP-1 side-effect analysis and comparative meta-analyses (PMC): Research Use Only Notice: The content on this page is provided for informational and educational purposes only
42 KiyoharaY
Products are sold for research use only (RUO), are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S
How do I know if my hair loss is due to B12 deficiency
The hypersensitive response facilitates plant infection by the necrotrophic pathogen Botrytis cinerea
Visser, N., Bauer, N
US$ 21.84
US$ 29.35
US$ 24.49
US$ 27.37
US$ 27.78
US$ 29.47
US$ 24.62
US$ 22.74
US$ 25.31